

Related Companies | [] | ||||||||
Related Funds | [] | ||||||||
English | |||||||||
oda_WinningATenderAbstract| |
| ||||||||
oda_UpdateAnnouncementFlag| |
| Hayır (No) | |||||||
oda_CorrectionAnnouncementFlag| |
| Hayır (No) | |||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject| |
| - | |||||||
oda_DelayedAnnouncementFlag| |
| Hayır (No) | |||||||
oda_AnnouncementContentSection| |
| ||||||||
oda_SubjectOfTender| |
| MANUEL/TAM OTOMATİK İNFÜZYON KEMOTERAPİSİ HİZMET ALIMI | |||||||
oda_PartyOpenedTender| |
| ŞAHİNBEY ARAŞTIRMA VE UYGULAMA HASTANESİ BAŞHEKİMLİĞİ | |||||||
oda_BoardDecisionOnBidForTender| |
| - | |||||||
oda_OtherPartiesIfParticipatedInTheTenderAsAGroup| |
| - | |||||||
oda_ShareOfTheCompanyIfParticipatedInTheTenderAsAGroup| |
| - | |||||||
oda_DateOfTenderBid| |
| 26/03/2026 | |||||||
oda_EndingUpDateOfTheTender| |
| 26/03/2026 | |||||||
oda_TenderResult| |
| Kesinleşen İhale Kararı Beklenmektedir | |||||||
oda_TenderValue| |
| 141.051.834,15 | |||||||
oda_ShareOfCompanyInTenderValue| |
| - | |||||||
oda_RatioOfTenderValueCorporateShareAmountToGrossSalesRevenueOnPubliclyDisclosedTheLatestFinancialStatementOfCompany| |
| - | |||||||
oda_ExplanationSection| |
| ||||||||
oda_ExplanationTextBlock| | Our Company has participated in the tender titled "36-Month Manual/Fully Automatic Infusion Chemotherapy Service Procurement" held on March 26, 2026 by the Chief Physician's Office of Gaziantep University Şahinbey Research and Application Hospital. According to the data announced on the Electronic Public Procurement Platform (EKAP), among the three bidders participating in the tender, our Company's bid, amounting to TRY 141,051,834.15, has been determined as the most economically advantageous offer. The tender process is ongoing, and the final tender decision is awaited to be notified to our Company. Respectfully announced to the public. The English translation of this disclosure is attached hereto; in the event of any discrepancy between the texts, the Turkish version shall prevail. | ||||||||
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.